XRAYDENTSPLY SIRONA Inc.

$8.84-31% 1Y

The financials

DENTSPLY SIRONA Inc. by the numbers

DENTSPLY SIRONA Inc. (XRAY) reported revenue of $898M in Q2 2026 (quarter ended Jun 30, 2026), down 4.1% from the same quarter a year earlier. That came with a gross margin of 55% and net income of $37M (4.1% of revenue). For the full year FY2025, revenue was $3.68B (−3.0% year on year) and net income −$598M. Its largest product in Q2 2026 was Implants And Prosthetics at $157M, 36% of the disclosed total, just ahead of Equipment And Instruments at 31%. The next results filing is expected around Nov 5, 2026, the same week as a year ago.

DENTSPLY SIRONA Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Revenue$898M$936M−4.1%
Gross profit$493M$490M+0.6%
Operating income$82M−$128Mto a profit
Net income$37M−$45Mto a profit
Diluted EPS$0.18−$0.22to a profit
Revenue by product, Q2 2026, as reported to the SEC
ProductRevenueShare
Implants And Prosthetics$157M36%
Equipment And Instruments$137M31%
CADCAM$102M23%
Orthodontics$40M9.2%

Business segments

Revenue split by product segment, from SEC XBRL filings.

Latest period: Jun 2026Total $436.0M (-2.0%)
Equipment And Instruments grew +0.74% year on yearOrthodontics -37% year on year
  • Implants And Prosthetics$157.0Mquarter on quarter +1.9%year on year -3.7%
  • Equipment And Instruments$137.0Mquarter on quarter +1.5%year on year +0.74%
  • CADCAM$102.0Mquarter on quarter -8.1%year on year -4.7%
  • Orthodontics$40.0Mquarter on quarter -11%year on year -37%
Segment sum = 49% of reported consolidated revenue (partial disaggregation) · Latest source: 10-Q filed Aug 6, 2026, SEC EDGAR